2m 2m 2m 2m 2m 2m 2m
BioAffinity (BIAF)
NASDAQ
$0.70+$0.00010 (+0.01%)
Price as of Jul 14, 2026 6:10 AM EDT- $4.4MMarket Cap
- -91.87%1-Year Change
- Diagnostics & ResearchIndustry
BioAffinity (BIAF)
$0.70+$0.00010 (+0.01%)
BIAF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.70 | ||
Change | -$0.07 (-8.70%) | ||
Open | $0.76 | ||
High | $0.77 | ||
Low | $0.61 | ||
Previous Close | $0.77 | ||
Volume | 430,517 | ||
30-Day Average Volume | 776,666 | ||
1-Week Change | -13.40% | ||
1-Month Change | -52.71% | ||
1-Year Change | -91.87% | ||
3-Year Change | -98.67% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 6.3M | ||
Total Assets | $7.9M | ||
Market Cap | $4.4M | ||
Enterprise Value | $1.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | N/A | ||
Free Cash Flow | -$3.2M | ||
EBIT | $0.00 | ||
EBITDA | $114,518.00 | ||
Net Working Capital | $1.2M | ||
EPS | -$0.81 | ||
Enterprise Value/EBITDA | 12 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 09/19/2025 | ||
Earnings & Revenue